Chandru Vijay bought LTRN

June 15, 2020 · Form 4 insider transaction

Chandru Vijay bought 9,135 shares of Lantern Pharma Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1926 days after the transaction.

Direction
Acquired (buy-side)
Shares
9,135
Price
$0.00
Total value
N/A
Role
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 15, 2020
Filing dateSeptember 23, 2025
Shares owned after9,135
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The two reported transactions involve an amendment of an outstanding option for purposes of reducing the option exercise price, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 15, 2020 and provides for vesting in equal monthly increments over a 36-month period commencing July 15, 2020.

View the original Form 4 on SEC EDGAR